US Small Caps: The Opportunity Is No Longer Theoretical

For years, the argument for US small caps was straightforward, but difficult to underwrite. Valuations were attractive, relative returns had been disappointing, and investor positioning was light. Yet the market continued to reward scale, liquidity and mega-cap earnings certainty. Small caps were cheap, but cheapness alone was not enough.

That has changed.

The opportunity within US small caps is no longer theoretical. Performance has begun to validate it. Valuations continue to support it. Market structure makes it actionable. In our view, investors should now be asking a different question: not whether US small caps deserve a role in portfolios, but whether current allocations are large enough for the opportunity now emerging.

The first driver is valuation. US large-cap equities remain highly concentrated and increasingly valuation-sensitive. A narrow group of mega-cap companies has absorbed a disproportionate share of global equity flows, leaving many portfolios with greater exposure to elevated multiples, ambitious earnings expectations and AI-led capital expenditure cycles than investors may fully appreciate. This does not mean large caps cannot continue to perform. It means the margin for disappointment has narrowed.

Small caps offer a different starting point. After years of underperformance, many high-quality smaller companies now trade on valuations that already discount substantial macro uncertainty, financing risk and earnings volatility. That is what makes the current set-up compelling. The asset class is no longer merely cheap in isolation; it is attractively valued relative to an extended large-cap market, and it is now beginning to work.

But this is where investors must be careful. The correct conclusion is not to buy the Russell 2000 indiscriminately. The benchmark is a useful representation of the US small-cap universe, but it is a poor substitute for judgement.

Almost 40% of Russell 2000 constituents are unprofitable. That matters. In a higher-rate world, the difference between a company able to self-fund growth and one dependent on refinancing, equity issuance or favourable capital markets is fundamental. Passive exposure allocates capital to both. Active management does not have to.

The index also contains a structural asymmetry that is often overlooked. The best small-cap companies do not remain small caps. They graduate. The lower-quality tail persists. The June 2026 Russell rebalance illustrates this clearly: 43 companies are moving from the Russell 2000 into the Russell 1000. Bloom Energy is the most striking example, having moved from the small-cap universe towards the Russell Top 200 after a powerful AI-power-infrastructure re-rating. This is not a criticism of the company. It is a critique of passive benchmark mechanics. The index can capture a winner late, allow it to dominate returns, and then lose it as it migrates up the market-cap spectrum.

This is why we do not believe active management is merely preferable in US small caps. We believe it is essential.

For Qualis, the opportunity lies in identifying the future graduates before they become obvious. The focus should be on businesses with positive or improving free cash flow, resilient balance sheets, disciplined management teams, defendable niches and credible pathways from small-cap valuation to mid-cap quality.

Importantly, the most attractive areas are not simply cyclical recovery trades. They include companies exposed to domestic industrial investment, electrification, infrastructure, defence, automation, reshoring and selective financials — areas where structural demand can support earnings beyond the next quarter.

This is the core of the Qualis perspective. We are not advocating a blind rotation into smaller companies. We are making the case for a deliberate increase in actively managed US small-cap exposure because the conditions now justify it.

Performance has begun to support the call. Valuations continue to reinforce it. Large-cap concentration increases the need for diversification. Benchmark composition increases the need for selectivity. And dispersion within the small-cap universe provides the raw material for alpha.

US small caps have moved from valuation anomaly to allocation opportunity. Investors waiting for the index to look perfect may miss the window, because the index will never look perfect. That is the point. The inefficiency is the opportunity.

Our view is clear: now is the time to consider increasing allocations to actively managed US small caps, not as a passive benchmark trade, but as a selective allocation to tomorrow’s mid-cap compounders, improving free-cash-flow businesses and companies whose recovery remains under-owned, under-researched and underappreciated.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and investors may get back less than they originally invested.

This article is for information only and does not constitute investment advice or a personal recommendation.